Capital Growth on Instagram: "Billions of dollars are poured into cancer research every single year, but despite that, survival rates for cancers like pancreatic have barely improved over the last few decades, and it still remains one of the deadliest diseases on earth. But now, a small biotech has developed a therapy that’s more than doubling survival outcomes, and it could become the first immunotherapy approved in one of the deadliest cancers known to man. That company is Oncolytics Biotech,

Does The Phoenix Device Really Work for ED?-My In-Depth Review - Optimize Health 365